Ziccum Investor Relations Material

Ziccum is a Sweden-based pharmaceutical company specializing in the development of vaccines. It focuses on creating new thermostable versions of vaccines and biologics through its patented drying technology, LaminarPace. This unique method relies on mass transfer instead of heat transfer, enabling the production of particle-engineered, thermostable dry powder biopharmaceuticals. These powders can be easily handled and transported, and they are suitable for novel administration routes, eliminating the need for cold chain logistics. The company is headquartered in Lund, Sweden, and its shares are listed on the Nasdaq Stockholm.